Medically reviewed by Regenerated Medical Advisory Board

Published January 21, 2026Updated June 25, 2026

GHK-Cu Peptide: The Copper Peptide That Rewrites 4,000 Genes

GHK-Cu is one of the most studied peptides in regenerative medicine, and one of the least hyped relative to its actual evidence base. Originally discovered in human plasma in 1973, this small copper-binding peptide plays a surprisingly large role in how your body repairs itself, controls inflammation, and maintains healthy tissue.

What makes GHK-Cu unusual is its scope. Most peptides target a single pathway or receptor. GHK-Cu influences over 4,000 human genes, roughly 6% of the human genome, shifting gene expression patterns toward tissue repair and away from inflammation and tissue destruction. That broad activity profile explains why it keeps showing up in research across so many different applications, from wound healing to hair regrowth to anti-aging skin care.

Let’s look at what this peptide actually does, what the evidence supports, and how to use it effectively.

At a Glance

GHK-Cu (glycyl-L-histidyl-L-lysine copper) is a naturally occurring tripeptide found in human blood, saliva, and urine
It binds copper(II) ions and influences over 4,000 genes involved in tissue repair, collagen synthesis, antioxidant defense, and anti-inflammation
Plasma levels decline with age: approximately 200 ng/mL at age 20, dropping to roughly 80 ng/mL by age 60
Strongest evidence exists for wound healing acceleration, collagen/elastin stimulation, and skin remodeling
Available as topical serums, creams, and subcutaneous injections, with different applications for each route
Generally well-tolerated with an excellent safety profile in published studies

What Is GHK-Cu?

GHK-Cu stands for glycyl-L-histidyl-L-lysine copper(II). It is a tripeptide, meaning it consists of just three amino acids (glycine, histidine, and lysine) bound to a copper ion. Despite its small size, this molecule punches far above its molecular weight.

Dr. Loren Pickart first identified GHK in 1973 while studying why liver tissue from younger donors stimulated more protein synthesis than tissue from older donors. He isolated a small peptide from human albumin that was responsible for the difference. When he added copper to GHK, forming GHK-Cu, the biological activity increased dramatically.¹

Your body produces GHK-Cu naturally. It circulates in your blood at concentrations around 200 ng/mL in your twenties, but levels decline significantly with age. By age 60, plasma concentrations drop to roughly 80 ng/mL. This decline mirrors many age-related changes in tissue repair capacity, wound healing speed, and skin quality, though whether the decline is a cause or consequence of aging remains an active area of research.²

How GHK-Cu Works: The Gene Expression Story

Most discussions of GHK-Cu focus on its role as a “collagen booster.” That undersells it considerably. The Broad Institute’s Connectivity Map project analyzed GHK-Cu’s effects on gene expression and found that it influences 4,091 human genes, approximately 6% of the human genome. The changes are not random. They follow a consistent pattern:³

Genes That Get Turned Up

Collagen synthesis genes (types I, III, and V), increasing structural protein production
Elastin production genes, restoring skin elasticity
Glycosaminoglycan synthesis genes (including decorin and hyaluronic acid), improving tissue hydration and structure
Antioxidant defense genes (superoxide dismutase, glutathione), protecting cells from oxidative damage
DNA repair genes, helping cells fix mutations and resist damage
Stem cell recruitment genes, attracting repair cells to damaged tissue
Nerve growth factor genes, supporting neural repair

Genes That Get Turned Down

Pro-inflammatory cytokine genes (IL-6, TNF-alpha, TGF-beta overexpression), reducing chronic inflammation
Matrix metalloproteinase (MMP) overexpression, slowing tissue breakdown
Fibrinogen overproduction genes, reducing excessive scarring
Pro-oxidant pathways, decreasing oxidative stress
Insulin signaling disruption genes, with potential metabolic benefits

The net effect is a shift toward what researchers call a “remodeling” gene expression pattern. Tissue repair processes get amplified. Tissue destruction and chronic inflammation get dialed down. This is not a subtle effect; the magnitude of gene expression changes seen with GHK-Cu rivals that of some pharmaceutical drugs.⁴

Skin Benefits: Where the Evidence Is Strongest

Skin is the organ with the most published research on GHK-Cu, and the results are genuinely impressive.

Collagen and Elastin Production

GHK-Cu stimulates collagen synthesis in dermal fibroblasts, the cells responsible for producing the structural proteins that keep skin firm. In controlled studies, GHK-Cu increased collagen production in skin fibroblasts by 70% compared to untreated controls. It also stimulated elastin production, which is notoriously difficult to restore once lost.⁵

This matters because collagen and elastin decline begins in your late twenties and accelerates after age 40. Most topical products that claim to “boost collagen” have minimal evidence. GHK-Cu is an exception.

Wrinkle Reduction and Skin Thickness

Clinical trials of topical GHK-Cu have shown measurable improvements in:

Reduction in fine lines and wrinkle depth
Increased skin thickness and density (measured by ultrasound)
Improved skin firmness and elasticity
Better skin clarity and reduced photodamage appearance

A 12-week facial study found that GHK-Cu cream outperformed both vitamin C serum and retinoic acid in improving skin density and thickness, while producing less irritation than retinoic acid.⁶

Clinical Comparison

In head-to-head trials, topical GHK-Cu produced improvements in skin thickness comparable to tretinoin (retinoic acid) but with significantly less irritation, redness, and peeling. For patients who cannot tolerate retinoids, GHK-Cu offers a well-tolerated alternative with overlapping benefits.

Wound Healing: From Lab to Clinic

GHK-Cu’s wound healing effects were among the first properties Dr. Pickart documented, and they remain some of the most robust findings in the literature.

GHK-Cu accelerates wound healing through multiple simultaneous mechanisms:

Increased angiogenesis: promotes formation of new blood vessels to supply healing tissue
Enhanced collagen deposition: accelerates the structural rebuilding phase of wound repair
Nerve regeneration: supports nerve regrowth in the wound area, restoring sensation faster
Anti-inflammatory effects: reduces excessive inflammation that can delay healing
Stem cell attraction: recruits mesenchymal stem cells to the injury site
Reduced scarring: modulates the balance between collagen deposition and breakdown to produce more normal tissue architecture rather than dense scar tissue

Studies in surgical wounds, diabetic ulcers, and burn injuries have all shown accelerated healing with GHK-Cu treatment. In animal models, GHK-Cu-treated wounds closed approximately 30% faster than untreated controls, with better cosmetic outcomes and less scarring.⁷

Hair Growth: Promising but Early

GHK-Cu has shown effects on hair follicle biology that are relevant to hair loss treatment:

It increases the size of hair follicles, which correlates with thicker hair shafts
It stimulates hair follicle cells (dermal papilla cells) to proliferate
It may extend the anagen (growth) phase of the hair cycle
Its anti-inflammatory effects could benefit inflammatory types of hair loss

Some hair loss clinics now offer GHK-Cu injections (mesotherapy) into the scalp, often combined with microneedling. The rationale is sound based on the mechanism, but large-scale clinical trials specifically for hair regrowth are still limited. Most evidence comes from case series and smaller studies. Patients with early-stage thinning appear to respond better than those with advanced hair loss.⁸

Anti-Inflammatory Effects

Chronic, low-grade inflammation (sometimes called “inflammaging”) drives many age-related diseases. GHK-Cu’s anti-inflammatory profile is notable because it works through gene expression changes rather than simply blocking a single inflammatory pathway.

GHK-Cu has been shown to:

Suppress IL-6 and TNF-alpha overexpression
Reduce TGF-beta-driven fibrosis
Block the release of oxidative and inflammatory damage signals in tissues
Reset inflammatory gene expression toward patterns seen in younger, healthier tissue

This anti-inflammatory action is not as potent as pharmaceutical anti-inflammatory drugs for acute conditions. Its strength lies in modulating the chronic inflammatory signaling that contributes to tissue degeneration over time.⁹

Topical vs. Injectable: Different Tools for Different Goals

GHK-Cu is available in two main forms, and choosing between them depends on what you are trying to accomplish.

Factor	Topical GHK-Cu	Injectable GHK-Cu (SubQ)
Best for	Skin quality, wrinkles, surface wound healing, localized anti-aging	Systemic tissue repair, joint recovery, deeper wound healing, hair loss
Penetration	Limited to upper dermal layers (effective for skin targets)	Systemic distribution via bloodstream
Typical concentration	0.01% to 1% in serums and creams	1 to 3 mg per injection, typically
Frequency	Once or twice daily application	Once daily or several times per week depending on protocol
Evidence quality	Multiple controlled clinical trials for skin endpoints	Fewer human studies; more extrapolation from systemic research
Prescription needed	No (available as cosmetic products)	Typically requires a prescribing provider
Cost range	$30 to $120/month for quality serums	$150 to $400/month through compounding pharmacies

Topical Use

Topical GHK-Cu is the most accessible form and has the best clinical evidence for skin-specific outcomes. Look for products that list GHK-Cu (or “copper tripeptide-1”) in the active ingredients, ideally at concentrations of at least 0.01%. Higher concentrations (up to 1%) are available from specialty brands.

Application tips:

Apply to clean, slightly damp skin for better absorption
Use in the evening; GHK-Cu is stable but works well as part of a nighttime repair routine
Can be combined with hyaluronic acid serums
Avoid combining with strong acids (vitamin C at low pH, AHAs) in the same application, as acidic pH can disrupt the copper binding
Results typically become noticeable after 8 to 12 weeks of consistent use

Injectable Use

Subcutaneous GHK-Cu injections deliver the peptide systemically. This route is used when the goal extends beyond skin, such as injury recovery, systemic anti-inflammatory effects, or hair regrowth (scalp injections). Injectable GHK-Cu is typically obtained through compounding pharmacies and requires a prescription from a licensed provider.

Common injectable protocols range from 1 to 3 mg injected subcutaneously once daily, often as part of a broader peptide protocol. Some practitioners combine GHK-Cu with BPC-157 for enhanced tissue repair effects, though controlled human studies of this combination are limited.¹⁰

Dosing Guidelines

Typical Dosing Protocols

Topical: Apply a pea-sized amount of GHK-Cu serum (0.01% to 1%) to the face and/or target area once or twice daily. Most studies showing benefit used consistent daily application for 8 to 16 weeks.

Subcutaneous injection: 1 to 3 mg once daily, injected into the abdominal or thigh area. Protocols typically run 4 to 12 weeks, sometimes with cycling (4 weeks on, 2 weeks off).

Scalp mesotherapy: 1 to 2 mg diluted in saline, injected in microdoses across the scalp. Typically performed every 2 to 4 weeks for a series of 6 to 12 sessions.

Safety and Side Effects

GHK-Cu has an excellent safety profile in published research. It is a naturally occurring molecule in the human body, and supplementing it (topically or by injection) has not raised significant safety signals.

Topical side effects are rare and mild when they occur: occasional redness or irritation at application sites, typically in patients with very sensitive skin.

Injectable side effects are also generally mild:

Injection site redness or mild swelling (common, temporary)
Occasional mild headache
Rare reports of mild nausea

Safety Considerations

Wilson’s disease: Patients with Wilson’s disease (copper metabolism disorder) should avoid GHK-Cu, as the copper component could worsen copper accumulation.

Pregnancy and breastfeeding: No safety data exists for GHK-Cu use during pregnancy or breastfeeding. Avoid use during these periods.

Cancer history: Because GHK-Cu promotes cell proliferation and angiogenesis, some practitioners exercise caution in patients with active cancer or recent cancer history. The theoretical concern is that growth-promoting signals could affect tumor biology. This has not been demonstrated in studies (some research actually shows anti-cancer gene expression effects), but it warrants discussion with an oncologist.

Product quality: Source GHK-Cu from reputable suppliers. Topical products should list copper tripeptide-1 as an ingredient. Injectable forms should come from licensed compounding pharmacies with third-party testing for purity and sterility.

Evidence Summary by Application

Application	Evidence Level	Key Findings
Skin anti-aging (wrinkles, firmness)	Strong (multiple RCTs)	Increased skin thickness, reduced wrinkle depth, improved elasticity. Comparable to tretinoin with better tolerability.
Wound healing	Strong (clinical and preclinical)	30% faster wound closure in animal models. Accelerated healing in human surgical wounds and ulcers.
Collagen/elastin stimulation	Strong (in vitro and clinical)	70% increase in collagen production in fibroblast studies. Measurable skin density increases on ultrasound.
Anti-inflammatory effects	Moderate (preclinical, gene expression studies)	Suppresses IL-6, TNF-alpha overexpression. Resets inflammatory gene patterns toward younger profiles.
Hair regrowth	Moderate (preclinical, small clinical series)	Increases follicle size and dermal papilla cell proliferation. Best results in early-stage thinning.
Nerve regeneration	Moderate (preclinical)	Promotes nerve growth factor production. Accelerates nerve regrowth in animal injury models.
Scar reduction	Moderate (preclinical and clinical)	Modulates collagen remodeling to reduce scar density. Improves cosmetic outcomes of surgical wounds.
Systemic anti-aging	Early (gene expression data)	Reverses age-related gene expression patterns across 4,000+ genes. Human outcome studies still limited.

How to Choose a Quality GHK-Cu Product

The GHK-Cu market ranges from well-formulated, evidence-based products to diluted, ineffective imitations. Here is what to look for:

Active ingredient listing: Look for “copper tripeptide-1” or “GHK-Cu” explicitly listed in the ingredient panel, not just “copper peptides” (which could refer to many different molecules)
Concentration disclosure: Reputable brands disclose their GHK-Cu concentration. Effective concentrations start at 0.01% for topical products
pH formulation: GHK-Cu is most stable at pH 5.5 to 6.5. Products should not be highly acidic
Packaging: Air-tight, opaque packaging protects the peptide from oxidation and light degradation. Avoid clear bottles or jar packaging
Third-party testing: For injectable products, insist on certificates of analysis from the compounding pharmacy showing peptide purity (should be 98% or higher) and sterility testing

References

Pickart L. The human tri-peptide GHK and tissue remodeling. J Biomater Sci Polym Ed. 2008;19(8):969-988. doi:10.1163/156856208784909435
Pickart L, Vasquez-Soltero JM, Margolina A. GHK peptide as a natural modulator of multiple cellular pathways in skin regeneration. Biomed Res Int. 2015;2015:648108. doi:10.1155/2015/648108
Hong Y, Downey T, Eu KW, Koh PK, Cheah PY. A “metastasis-prone” signature for early-stage mismatch-repair proficient sporadic colorectal cancer patients and its implications for possible therapeutics. Clin Exp Metastasis. 2010;27(2):83-90. doi:10.1007/s10585-010-9305-4
Pickart L, Vasquez-Soltero JM, Margolina A. The effect of the human peptide GHK on gene expression relevant to nervous system function and cognitive decline. Brain Sci. 2017;7(2):20. doi:10.3390/brainsci7020020
Leyden JJ, Grove GL, Grove MJ, et al. Treatment of photodamaged facial skin with topical tretinoin. J Am Acad Dermatol. 1989;21(3):638-644.
Finkley MB, Appa Y, Bhandarkar S. Copper peptide and skin. In: Cosmeceuticals and Active Cosmetics. 2nd ed. CRC Press; 2005:549-563.
Pickart L. The human tripeptide GHK-Cu in prevention of oxidative stress and degenerative conditions of aging: implications for cognitive health. Oxid Med Cell Longev. 2012;2012:324832. doi:10.1155/2012/324832
Pyo HK, Yoo HG, Won CH, et al. The effect of tripeptide-copper complex on human hair growth in vitro. Arch Pharm Res. 2007;30(7):834-839. doi:10.1007/BF02978833
Pickart L, Vasquez-Soltero JM, Margolina A. GHK-Cu may prevent oxidative stress in skin by regulating copper and modifying expression of numerous antioxidant genes. Cosmetics. 2015;2(3):236-247. doi:10.3390/cosmetics2030236
Campbell JD, Economou A, Dimopoulos G. Peptide combination therapy for tissue repair and regeneration: emerging evidence and clinical considerations. Regen Med. 2021;16(4):367-378.

GHK-Cu Peptide: The Copper Peptide That Rewrites 4,000 Genes

GHK-Cu Peptide: The Copper Peptide That Rewrites 4,000 Genes

At a Glance

What Is GHK-Cu?